Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.